| 2 | 1/1 | 返回列表 |
| 查看: 566 | 回復: 1 | |||
| 本帖產(chǎn)生 1 個 翻譯EPI ,點擊這里進行查看 | |||
swlhlbr新蟲 (初入文壇)
|
[求助]
大神幫幫忙~幫我翻譯一下中文摘要(300字)~非常感謝~
|
||
|
目的:通過將門診發(fā)生的藥品不良反應(yīng)計入門診電子病歷,保證門診所發(fā)生藥品不良反應(yīng)的可追溯性,在加強臨床個體化用藥安全的同時促進對上市藥品的安全質(zhì)量監(jiān)控,保障廣大患者的用藥安全。方法:成立品管圈活動小組,遵循PDCA程序,活用品管圈七大手法,分析門診藥品不良反應(yīng)難以溯源的原因,探索對策,予以實施并評估活動效果。 結(jié)果:比較活動前、后各項藥品不良反應(yīng)可溯源指標均得到了明顯改善,門診藥品不良反應(yīng)計入病歷率由改善前31%升至改善后90.1%,活動后門診退藥登記表確認簽名率達87.2%,活動達標率為105.6%。結(jié)論:本次品管圈活動有效的提高了門診藥品不良反應(yīng)計入病歷的質(zhì)量,患者承諾簽名一定程度的保證了門診藥品不良反應(yīng)的真實性,保證了門診藥品不良反應(yīng)的可溯源性,為藥品的臨床合理使用提供了依據(jù)。 關(guān)鍵詞:藥品不良反應(yīng),品管圈,溯源 |
捐助貴賓 (著名寫手)
商家已經(jīng)主動聲明此回帖可能含有宣傳內(nèi)容|
目的:通過 將門診 發(fā)生的 藥品不良反應(yīng) 計入 門診 電子病歷,保證門診 所發(fā)生 藥品不良反應(yīng)的 可追溯性,在加強 臨床 個體化 用藥安全的 同時 促進 對上市藥品的 安全質(zhì)量監(jiān)控,保障 廣大患者的 用藥安全。方法:成立 品管圈 活動小組,遵循 PDCA程序,活用 品管圈 七大手法,分析 門診藥品 不良反應(yīng) 難以溯源的 原因,探索 對策,予以 實施并評估 活動效果。 結(jié)果:比較 活動前、后 各項 藥品不良反應(yīng) 可 溯源指標 均得到了 明顯改善,門診藥品 不良反應(yīng) 計入 病歷率 由改善前31%升 至改善后 90.1%,活動后 門診退藥登記表 確認簽名率 達87.2%,活動達標率 為105.6%。結(jié)論:本次 品管圈活動 有效的 提高了 門診藥品不良反應(yīng) 計入病歷的 質(zhì)量,患者 承諾簽名 一定程度的 保證了 門診藥品不良反應(yīng)的 真實性,保證了 門診藥品不 良反應(yīng)的 可溯源性,為 藥品的 臨床合理 使用提供了依據(jù)。 Purpose: Guarantee the traceability of adverse drug reactions occurred during outpatient treatment by recording them into electronic medical record(EMR), and enhance monitoring the safety and quality of drugs on current market in the meantime of strengthening individual medication safety, so as to secure the medication safety for massive patients. Method: Establish activity groups of quality control circle, follow PDCA procedures and flexibly use the QC 7 basic tools, analyze the reason why adverse drug reactions can hardly be traced, explore countermeasures, implement activity and evaluate activity effect. Results: Through comparing the traceability indexes of adverse drug reactions before and after the implementation of activity, it shows that the traceability indexes have been improved, and the rate of successfully recording adverse drug reactions into EMR has been increased from 31% before improvement to 90.1% after improvement, in addition, the signature rate on drug withdrawal list after implementation of activity can reach 87.2%, and the rate of reaching the standard in activity reached 105.6%. Conclusion: The QCC activity effectively improved the quality of recording adverse drug reactions into EMR. Patient's commitment to signature on drug withdrawal list guarantees the authenticity and traceability of adverse drug reactions, providing basis for clinical rational drug use. 關(guān)鍵詞:藥品不良反應(yīng),品管圈,溯源 Keywords: Adverse Drug Reaction, Quality Control Circle; Traceability |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 287求調(diào)劑 +11 | land xuxu 2026-03-26 | 11/550 |
|
|---|---|---|---|---|
|
[考研] 277跪求調(diào)劑 +7 | 1915668 2026-03-27 | 11/550 |
|
|
[考研] 材料專碩調(diào)劑 +9 | 椰椰。 2026-03-29 | 9/450 |
|
|
[考研] 一志愿哈爾濱工業(yè)大學材料與化工方向336分 +11 | 辰沐5211314 2026-03-26 | 11/550 |
|
|
[考研] 一志愿太原理工安全工程300分,求調(diào)劑 +5 | 0857求調(diào)劑. 2026-03-24 | 6/300 |
|
|
[考研] 食品工程專碩一志愿中海洋309求調(diào)劑 +4 | 小張zxy張 2026-03-26 | 8/400 |
|
|
[考研] 394求調(diào)劑 +3 | 好事多磨靜候佳?/a> 2026-03-26 | 5/250 |
|
|
[考研] 張芳銘-中國農(nóng)業(yè)大學-環(huán)境工程專碩-298 +4 | 手機用戶 2026-03-26 | 4/200 |
|
|
[考研] 材料求調(diào)劑 一志愿哈工大總分298分,前三科223分 +5 | dongfang59 2026-03-27 | 5/250 |
|
|
[考研] 求調(diào)劑 +4 | 零八# 2026-03-27 | 4/200 |
|
|
[考研] 274求調(diào)劑 +17 | 顧九笙要謙虛 2026-03-24 | 23/1150 |
|
|
[考研] 調(diào)劑 +3 | 李嘉圖·S·路 2026-03-27 | 3/150 |
|
|
[考研] 351求調(diào)劑 +4 | 麥克阿磊 2026-03-24 | 4/200 |
|
|
[考研] 0703化學求調(diào)劑 +3 | 丹青奶蓋 2026-03-26 | 5/250 |
|
|
[考研] 一志愿天津大學339材料與化工求調(diào)劑 +3 | 江往賣魚 2026-03-26 | 3/150 |
|
|
[考研] 材料專碩 335 分求調(diào)劑 +4 | 拒絕冷暴力 2026-03-25 | 4/200 |
|
|
[考研] 求調(diào)劑 +6 | 研研,接電話 2026-03-24 | 7/350 |
|
|
[考研]
|
13659058978 2026-03-24 | 4/200 |
|
|
[考研] 一志愿吉大化學322求調(diào)劑 +4 | 17501029541 2026-03-23 | 6/300 |
|
|
[考研] 材料/農(nóng)業(yè)專業(yè),07/08開頭均可,過線就行 +3 | 呵唔哦豁 2026-03-23 | 4/200 |
|